Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | ACE | P12821 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.35 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.35 |
| ▸ | ICMT | O60725 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | METAP2 | P50579 | 1/20 | 0.33 |
| ▸ | METAP1 | P53582 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4955678 | 1.00 | ALDH1A1 (0.44) | ALDH1A1GAATAAR1ACEMAPT | |
| SCHEMBL4952143 | 0.91 | ALDH1A1 (0.42) | ALDH1A1GAATAAR1MAPTICMT | |
| SCHEMBL4952149 | 0.91 | ALDH1A1 (0.42) | ALDH1A1GAATAAR1MAPTICMT | |
| SCHEMBL4952677 | 0.87 | ALDH1A1 (0.47) | ALDH1A1GAATAAR1ACEMAPT | |
| SCHEMBL4952673 | 0.87 | ALDH1A1 (0.47) | ALDH1A1GAATAAR1ACEMAPT | |
| SCHEMBL4951953 | 0.86 | ALDH1A1 (0.43) | ALDH1A1GAATAAR1TAS1R3TAS1R1 | |
| SCHEMBL4951949 | 0.86 | ALDH1A1 (0.43) | ALDH1A1GAATAAR1TAS1R3TAS1R1 | |
| SCHEMBL4954310 | 0.84 | ACE (0.34) | ALDH1A1ACEMAPTICMTMETAP2 | |
| SCHEMBL4954308 | 0.84 | ACE (0.34) | ALDH1A1ACEMAPTICMTMETAP2 | |
| SCHEMBL4951996 | 0.82 | ALDH1A1 (0.52) | ALDH1A1GAATAAR1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7465471-B2 | Palatability of aquaculture feed | NOVUS INTERNATIONAL, INC. (US) | 2008-12-16 | — | — | US | disclosed |
| WO-2007147155-A1 | POLYOL ESTER COMPOUNDS | NOVUS INTERNATIONAL INC. (US) | 2007-12-21 | — | — | WO | disclosed |
| US-20070292485-A1 | POLYOL ESTER COMPOUNDS | NOVUS INTERNATIONAL INC. (US) | 2007-12-20 | — | — | US | disclosed |
| US-20050215623-A1 | Palatability of aquaculture feed | NOVUS INTERNATIONAL, INC. (US) | 2005-09-29 | — | — | US | disclosed |
| US-20040175434-A1 | Antimicrobial compositions | NOVUS INTERNATIONAL, INC. | 2004-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070292485-A1 | POLYOL ESTER COMPOUNDS | PNLIP, ELOVL1, ELOVL5 | ALDH1A1 679/4885GAA 319/4885TAAR1 4012/4885 |
| US-20050215623-A1 | Palatability of aquaculture feed | TAS2R3, TAS2R1, TAS2R20 | ALDH1A1 585/4885GAA 1395/4885TAAR1 1097/4885 |
| US-20040175434-A1 | Antimicrobial compositions | MRPL21, FPR1, ARG1 | ALDH1A1 2079/4885GAA 2335/4885TAAR1 3995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.